Month: June 2025

Form 8.3 – [GLOBALDATA PLC – 30 05 2025] – (CGWL)

Written by Customer Service on June 2, 2025. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree GLOBALDATA PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date position held/dealing...

Form 8.3 – [CRANEWARE PLC – 30 05 2025] – (CGWL)

Written by Customer Service on June 2, 2025. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree CRANEWARE PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date position held/dealing...

dsm-firmenich completes sale of its stake in Feed Enzymes Alliance to Novonesis for €1.5 billion

Written by Customer Service on June 2, 2025. Posted in Mergers And Acquisitions.

Press Release dsm-firmenich completes sale of its stake in Feed Enzymes Alliance to Novonesis for €1.5 billion Kaiseraugst (Switzerland), Maastricht (Netherlands), June 2, 2025 dsm-firmenich, innovators in nutrition, health, and beauty, today announces the successful completion of the sale of its stake in the Feed Enzymes Alliance to its partner Novonesis, a global leader in biosolutions, for €1.5 billion. The sale agreement was announced on February 11, 2025. dsm-firmenich received approximately €1.4 billion net in cash, after transaction costs. About dsm-firmenichAs innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned...

Novonesis completes acquisition of dsm-firmenichs’s share of the Feed Enzyme Alliance

Written by Customer Service on June 2, 2025. Posted in Mergers And Acquisitions.

Novonesis has successfully completed the acquisition of dsm-firmenich’s share of the Feed Enzyme Alliance following the satisfaction of all closing conditions. The acquisition was initially announced on February 11, 2025 (announcement No 2). Please read the full announcement in PDF.Attachment2025_Closing_of_the_Feed_Enzyme_Alliance

Dynacor Group Declares June 2025 Dividend

Written by Customer Service on June 2, 2025. Posted in Dividend Reports And Estimates.

MONTRÉAL, June 02, 2025 (GLOBE NEWSWIRE) — Dynacor Group Inc. (TSX: DNG) (“Dynacor“ or the “Corporation“) announced its monthly dividend payment for June 2025 in the amount of C$0.01333 per common share which will be payable on June 18, 2025, to shareholders of record as of the close of business on June 11, 2025. This dividend represents the sixty-third (63rd) dividend and fifty-third (53rd) monthly dividend payment made to shareholders. The Corporation’s monthly dividend qualifies as an “eligible dividend” for Canadian income tax purposes.The payment and increase of dividends are at the discretion of the Board and will depend on the Corporation’s financial results, cash requirements, prospects and other factors deemed relevant by the Board. About Dynacor Dynacor Group is an industrial ore processing company...

SAIC Announces First Quarter of Fiscal Year 2026 Results

Written by Customer Service on June 2, 2025. Posted in Earnings Releases And Operating Results.

Revenues of $1.88 billion; approximately 2% revenue growth Net bookings of $2.4 billion; book-to-bill ratio of 1.3 Net income of $68 million; Adjusted EBITDA(1) of $157 million or 8.4% of revenues Diluted earnings per share of $1.42; Adjusted diluted earnings per share(1) of $1.92 Cash flows provided by operating activities of $100 million; Free cash flow(1) of $(44) million Management reaffirms fiscal year 2026 guidanceRESTON, Va., June 02, 2025 (GLOBE NEWSWIRE) — Science Applications International Corporation (NASDAQ: SAIC), a premier Fortune 500 technology integrator driving our nation’s digital transformation across the defense, space, civilian, and intelligence markets, today announced results for the first quarter ended May 2, 2025. “Our performance in the first quarter reflects the steady progress we are...

GFG Announces Encouraging Phase 1 Drill Results from Pen Gold Project, Ontario

Written by Customer Service on June 2, 2025. Posted in Public Companies.

Gold and base metals mineralization intersected at multiple targets; exploration budget increased to support aggressive H2 program KEY HIGHLIGHTS:Chabot Target: 3.90 grams of gold per tonne (“g/t Au”) over 3.5 metres (“m”), including 9.62 g/t Au over 1 m near surface (PEN-25-100); second zone returned 2.6 g/t Au over 1.3 m with over 1% zinc (1). Alpha Target (Muskego North Shear Zone): 1.00 g/t Au over 1.0 m (MSK-25-004), confirming the down-dip extension of a 2022 bedrock sample that graded 5.18 g/t Au. Foxtrot, Bravo, Charlie, and Delta Targets: Multiple zones of stratabound and remobilized sulphide mineralization with elevated gold, copper, and zinc values in structurally and lithologically favorable settings. Pending results from an additional 5 drill holes at the Aljo Gold Target (“Aljo”) to be released as they become available....

Hyperscale Data Reports $219 Million in Assets at End of Q1 2025, Sells Minority Stake in Private Pharmaceutical Company for $4.65 Million as Part of Company Streamlining

Written by Customer Service on June 2, 2025. Posted in Public Companies.

Proceeds to Support Company’s Strategic Focus on Data Center Business LAS VEGAS, June 02, 2025 (GLOBE NEWSWIRE) — Hyperscale Data, Inc. (NYSE American: GPUS), a diversified holding company (“Hyperscale Data” or the “Company”), today announced the sale of its minority equity interest in a privately held pharmaceutical company for gross proceeds of $4.65 million in cash. Hyperscale Data purchased the equity position for $1.5 million in several closings between three and four years ago. This transaction is consistent with the Company’s ongoing strategy to exit non-core investments and concentrate capital and resources on its primary asset—a 617,000 square foot data center located in Michigan, which is being developed to support high-performance computing (“HPC”) workloads, including artificial intelligence (“AI”) applications. “As...

Piedmont REIT Signs over 500,000 SF of Leases Second Quarter-to-Date and Raises Full Year Leasing Guidance from 1.4 – 1.6 million SF to 1.8 – 2.0 million SF

Written by Customer Service on June 2, 2025. Posted in Public Companies.

YTD Leasing of over 850,000 SF Atlanta, June 02, 2025 (GLOBE NEWSWIRE) — Piedmont Office Realty Trust, Inc. (“Piedmont” or “the Company”) (NYSE:PDM), an owner of Class A office properties located primarily in the Sunbelt, announced today, that the Company is participating in this week’s Nareit REITWeek Investor Conference in New York City. The Company has completed over 500,000 square feet of leasing thus far in the second quarter, with 350,000 square feet related to new tenants. Approximately 70% of the new tenant leases are for currently vacant space and year-to-date leasing volume now totals over 850,000 square feet. Of note, the Company signed two new, large transactions in excess of 10 years – 93,000 square feet with a global professional services firm specializing in risk, strategy and people at Three Galleria...

Liquidia Schedules First Commercial Shipment of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with PAH and PH-ILD

Written by Customer Service on June 2, 2025. Posted in Public Companies.

YUTREPIA now available to be prescribed to patients via specialty pharmacies FDA approved YUTREPIA on May 23, 2025 Court denies United Therapeutics’ request for preliminary injunction and a temporary restraining order, clearing the path for full commercial launchMORRISVILLE, N.C., June 02, 2025 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, today announced that Liquidia is scheduled to make its first commercial shipment of YUTREPIA™ (treprostinil) inhalation powder, marking the first time YUTREPIA will be available to be prescribed to patients at specialty pharmacies. This milestone was achieved only five business days following the U.S. Food and Drug Administration (FDA) approval of YUTREPIA on May 23,...

Month: June 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals